SCHEMBL2024880

SCHEMBL2024880

COC1=C(O)C=CC(C=CC(=O)c2ccc(O)cc2)C1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 4/20 0.44
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
F3 P13726 2/20 0.43
P4HB P07237 1/20 0.43
CALM1 P0DP23 1/20 0.43
RAB9A P51151 1/20 0.43
MEN1 O00255 1/20 0.43
XDH P47989 1/20 0.43
CTSL P07711 5/20 0.41
CTSB P07858 4/20 0.41
MAOB P27338 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
DPP4 P27487 3/20 0.38
PTPN1 P18031 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2023335 0.83 MEN1 (0.47) MAPTALDH1A1KMT2AP4HBMEN1
SCHEMBL30932999 0.81 ALDH1A1 (0.33) ALDH1A1CA1CA2
SCHEMBL8421989 0.76 MAOB (0.43) CAPN1MAPTALDH1A1KMT2AF3
SCHEMBL29216365 0.73 ALOX5 (0.42) ALDH1A1TDP1
Phloretin SCHEMBL2157151 0.72 SLC5A1 (0.46) MAPTALDH1A1KMT2AMEN1TDP1
SCHEMBL27183113 0.72 NPC1 (0.41) MAPTALDH1A1KMT2ARAB9AMEN1
SCHEMBL31527828 0.72 NPC1 (0.41) MAPTALDH1A1KMT2ARAB9AMEN1
SCHEMBL28558468 0.71 RAB9A (0.49) MAPTALDH1A1KMT2ARAB9AMEN1
SCHEMBL13067941 0.70 CRHBP (0.44) CAPN1MAPTALDH1A1KMT2AF3
SCHEMBL31527884 0.67 MEN1 (0.48) MAPTALDH1A1KMT2AMEN1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9198451-B2 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners SYMRISE AG (DE) 2015-12-01 US disclosed
US-8778987-B2 Use of 4-hydroxychalcone derivatives for masking an unpleasant taste SYMRISE AG (DE) 2014-07-15 US disclosed
EP-2340719-B1 Aroma composition comprising o-coumaric acid to reduce or suppress undesirable taste impressions of sweeteners SYMRISE AG (DE) 2014-02-19 EP disclosed
EP-2220945-B1 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners SYMRISE AG (DE) 2013-03-27 EP disclosed
EP-2340719-A1 Aroma composition comprising o-coumaric acid to reduce or suppress undesirable taste impressions of sweeteners Symrise AG (DE) 2011-07-06 EP disclosed
US-20110158919-A1 AROMA COMPOSITION COMPRISING O-COUMARIC ACID TO REDUCE OR SUPPRESS UNDESIRABLE TASTE IMPRESSIONS OF SWEETENERS SYMRISE AG (DE) 2011-06-30 US disclosed
EP-2220945-A1 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners Symrise GmbH & Co. KG (DE) 2010-08-25 EP disclosed
US-20100151055-A1 Aroma Composition to Reduce or Suppress Undesirable Bitter and Astringent Taste Impressions of Sweeteners SYMRISE GMBH & CO. KG (DE) 2010-06-17 US disclosed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE TAS2R45, TAS2R43, TAS2R30 CAPN1 4224/4885MAPT 3371/4885ALDH1A1 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.